skip to main content

H.R. 2115: Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act

Call or Write Congress

React to this bill with an emoji

Save your opinion on this bill on a six-point scale from strongly oppose to strongly support

Add Note All Positions »
(About Ads | Hide These Ads)

To amend titles XI and XVIII of the Social Security Act to provide greater transparency for discounts provided by manufacturers, to include real-time benefit information as part of a prescription drug plan's electronic prescription program under the Medicare program, and for other purposes.

The bill’s titles are written by its sponsor.

Sponsor and status

Photo of sponsor Abigail Spanberger

Abigail Spanberger

Sponsor. Representative for Virginia's 7th congressional district. Democrat.

Thumbnail of bill text
Read Text »
Last Updated: Oct 29, 2019
Length: 7 pages
Introduced
Apr 8, 2019
116th Congress (2019–2021)
Status

Passed House (Senate next) on Oct 28, 2019

This bill passed in the House on October 28, 2019 and goes to the Senate next for consideration.

Prognosis
3% chance of being enacted according to Skopos Labs (details)
Source
Congress.gov

Position statements

What legislators are saying

“Slotkins Bill to Lower Prescription Drug Costs Passes House with Broad Bipartisan Support”
    — Rep. Elissa Slotkin [D-MI8] (Co-sponsor) on Oct 29, 2019

“U.S. House Passes Arrington-Spanberger-Boyle Bill to Increase Negotiation Transparency, Lower Costs of Prescription Drugs”
    — Rep. Jodey Arrington [R-TX19] (Co-sponsor) on Oct 29, 2019

“My Votes – Week of October 28”
    — Rep. Cathy McMorris Rodgers [R-WA5] on Nov 1, 2019

More statements at ProPublica Represent...

History

Apr 8, 2019
 
Introduced

Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.

Read Text »

May 21, 2019
 
Considered by Health

A committee held a hearing or business meeting about the bill.

Oct 28, 2019
 
Passed House (Senate next)

The bill was passed in a vote in the House. It goes to the Senate next.

thumbnail image of vote View Vote » Read Updated Text » See Changes »

If this bill has further action, the following steps may occur next:
—
 
Passed Senate

—
 
Signed by the President

H.R. 2115 is a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

Bills numbers restart every two years. That means there are other bills with the number H.R. 2115. This is the one from the 116th Congress.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“H.R. 2115 — 116th Congress: Public Disclosure of Drug Discounts and Real-Time Beneficiary Drug Cost Act.” www.GovTrack.us. 2019. June 5, 2020 <https://www.govtrack.us/congress/bills/116/hr2115>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.